St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 1999

Primary Completion Date

June 30, 2000

Conditions

Chronic Myeloproliferative DisordersFatigueLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous ConditionUnspecified Adult Solid Tumor, Protocol Specific

Interventions

DIETARY_SUPPLEMENT

St. John's wort

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00005805 - St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer | Biotech Hunter | Biotech Hunter